retatrutide phase 2 nejm 2023 obesity trial jastreboff ๐จBreaking: Retatrutide's first 3 T2D data just dropped. โธ A1C: โ2.0% at 40 weeks โธ Weight: โ36.6 lbs (โ16.8%) at 12 mg โธ No weight loss plateau โ curve still descending Retatrutide Results: Weight Loss Data
Description
But it covers the full range of tirzepatide dosing up to 15mg at most concentrations
Tchang doesnt recommend trusting a click chart
it includes the financial exploitation of individuals seeking genuine help for a serious health condition like obesity
Those given the supplement lost 11.9 pounds (5.4 kg) over 16 weeks, compared to only 2 pounds (0.9 kg) in the placebo group
